Report Overview

The Womens Health Drugs market size in Kenya stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Womens health is a perspective of prevention and treatment that looks at health concerns unique to females. Women constitute approximately half of the population of Kenya with 26.45 million. Emerging Women-Centric Diseases like Breast, Cervical cancer and PCOS in Kenya is a cause of concern as womens health is often neglected. According to World Health Organization (WHO), Only 45% of women in Kenya currently have access to contraceptives and abortion is still illegal in Kenya. According to GLOBOCAN 2020, Breast cancer accounts for 25.6% and Cervical Cancer (19.7%) of all cancer cases occurring in females in Kenya.



Market Drivers

The market is majorly driven by the rising burden of women-centric diseases like Post-menopausal Osteoporosis, Breast and Cervical cancers, and Poly-Cystic Ovarian Syndrome. Polycystic ovarian syndrome (PCOS) is one of the leading causes of infertility and affects approximately 10% of women of reproductive age in Kenya.

In Kenya, the prevalence of osteoporosis stands at 24.3% among women. It is often overlooked and undertreated because it is clinically silent unless it presents with a fracture.

Increasing levels of awareness related to early diagnosis and screening of breast and cervical cancers in females and available therapies are leading to a high growth.

Increased efforts by NGOs like PATH to educate women about menstrual and reproductive health and STDs is expected to contribute to the markets growth. PATHs Devices, Diagnostics, and Drugs to Address Womens Needs (D3AWN) Product Development Partnership is advancing a portfolio ofdevices, diagnostics, and drugsfor preventing and managing postpartum haemorrhage and preeclampsia/eclampsia in African markets.

However, the side effects caused by contraceptives are restraining market growth. There is misconception about the use of contraceptive among rural women which leads to low acceptance and utilization of contraceptives.